ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 17 Mar 2020
Last Applicant/ Owned by
430 E. 29th Street, 14th Floor
New York
NY
10016
Serial Number
86897013 filed on 04th Feb 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VOCUPLO
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 86897013
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 00135209-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st May 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 21st May 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| 27th Aug 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Aug 2019 | EXTENSION 5 GRANTED |
| 26th Aug 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 22nd Aug 2019 | TEAS EXTENSION RECEIVED |
| 22nd Aug 2019 | EXTENSION 5 FILED |
| 15th Mar 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Mar 2019 | EXTENSION 4 GRANTED |
| 13th Mar 2019 | TEAS EXTENSION RECEIVED |